Skip to main content

Advertisement

SpringerLink
Log in

Citrobacter infections in a general hospital: characteristics and outcomes

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

In this investigation, we sought to investigate the characteristics of Citrobacter spp. infections. A retrospective cohort study in a 700-bed, tertiary care, university hospital was carried out during the period from June 1994 to January 2006. Seventy-eight patients (70 adults) with Citrobacter spp. isolates were identified. C. freundii was more common (71.8%), followed by C. koseri (23.1%) and C. braakii (3.8%). The most common associated clinical syndromes were urinary tract infections (52.6% of cases, including eight cases of asymptomatic bacteriuria), as well as intra-abdominal (14.1%), surgical site (7.7%), skin and soft tissue (6.4%), and respiratory tract infections (6.4%). In 29.5% of patients, Citrobacter spp. isolates were associated to polymicrobial infections, principally at sites other than the urinary tract. Antibiograms of 38 consecutive Citrobacter spp. isolates (29 C. freundii) were available. Most active agents were colistin (100%), fosfomycin (100%), imipenem (97.4%), gentamicin (89.5%), nitrofurantoin (89.5%), ciprofloxacin (80.6%), and cefepime (73.7%). Most patients (82.1%) had at least one underlying illness. Combination antimicrobial therapy was administered in 28.2% of cases. One patient died during hospitalization. The length of hospital stay was longer in patients with polymicrobial compared to monomicrobial infections (23 versus 13 days, respectively, p = 0.02). The isolation of Citrobacter species, although rather infrequent, was clinically relevant in the great majority of cases. Further attention should be paid to these pathogens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Janda JM, Abbott SL, Cheung WK, Hanson DF (1994) Biochemical identification of citrobacteria in the clinical laboratory. J Clin Microbiol 32:1850–1854

    PubMed  CAS  Google Scholar 

  2. Brenner DJ, O’Hara CM, Grimont PA, Janda JM, Falsen E, Aldova E et al (1999) Biochemical identification of Citrobacter species defined by DNA hybridization and description of Citrobacter gillenii sp. nov. (formerly Citrobacter genomospecies 10) and Citrobacter murliniae sp. nov. (formerly Citrobacter genomospecies 11). J Clin Microbiol 37:2619–2624

    PubMed  CAS  Google Scholar 

  3. Hodges GR, Degener CE, Barnes WG (1978) Clinical significance of citrobacter isolates. Am J Clin Pathol 70:37–40

    PubMed  CAS  Google Scholar 

  4. Lipsky BA, Hook EW 3rd, Smith AA, Plorde JJ (1980) Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis 2:746–760

    PubMed  CAS  Google Scholar 

  5. Lavigne JP, Defez C, Bouziges N, Mahamat A, Sotto A (2007) Clinical and molecular epidemiology of multidrug-resistant Citrobacter spp. infections in a French university hospital. Eur J Clin Microbiol Infect Dis 26:439–441. doi:10.1007/s10096-007-0315-3

    Article  PubMed  Google Scholar 

  6. Mohanty S, Singhal R, Sood S, Dhawan B, Kapil A, Das BK (2007) Citrobacter infections in a tertiary care hospital in Northern India. J Infect 54:58–64. doi:10.1016/j.jinf.2006.01.015

    Article  PubMed  Google Scholar 

  7. Arens S, Verbist L (1997) Differentiation and susceptibility of Citrobacter isolates from patients in a university hospital. Clin Microbiol Infect 3:53–57

    Article  PubMed  Google Scholar 

  8. Pepperell C, Kus JV, Gardam MA, Humar A, Burrows LL (2002) Low-virulence Citrobacter species encode resistance to multiple antimicrobials. Antimicrob Agents Chemother 46:3555–3560. doi:10.1128/AAC.46.11.3555-3560.2002

    Article  PubMed  CAS  Google Scholar 

  9. Altmann G, Sechter I, Cahan D, Gerichter CB (1976) Citrobacter diversus isolated from clinical material. J Clin Microbiol 3:390–392

    PubMed  CAS  Google Scholar 

  10. Samonis G, Anaissie E, Elting L, Bodey GP (1991) Review of Citrobacter bacteremia in cancer patients over a sixteen-year period. Eur J Clin Microbiol Infect Dis 10:479–485. doi:10.1007/BF01963933

    Article  PubMed  CAS  Google Scholar 

  11. Doran TI (1999) The role of Citrobacter in clinical disease of children: review. Clin Infect Dis 28:384– 394. doi:10.1086/515106

    Article  PubMed  CAS  Google Scholar 

  12. Jones RN, Jenkins SG, Hoban DJ, Pfaller MA, Ramphal R (2000) In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997–1998. Int J Antimicrob Agents 15:111–118. doi:10.1016/S0924-8579(00)00152-7

    Article  PubMed  CAS  Google Scholar 

  13. Gupta N, Yadav A, Choudhary U, Arora DR (2003) Citrobacter bacteremia in a tertiary care hospital. Scand J Infect Dis 35:765–768. doi:10.1080/00365540310016376

    Article  PubMed  Google Scholar 

  14. Barlow M, Hall BG (2002) Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii. Antimicrob Agents Chemother 46:1190–1198. doi:10.1128/AAC.46.5.1190-1198.2002

    Article  PubMed  CAS  Google Scholar 

  15. Horan TC, Gaynes RP (2004) Surveillance of nosocomial infections. In: Mayhall CG (eds) Hospital epidemiology and infection control, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1659–1702

    Google Scholar 

  16. Falagas ME, Kavvadia PK, Mantadakis E, Kofteridis DP, Bliziotis IA, Saloustros E et al (2006) Morganella morganii infections in a general tertiary hospital. Infection 34:315–321. doi:10.1007/s15010-006-6682-3

    Article  PubMed  CAS  Google Scholar 

  17. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC (1996) Bacteremia due to Citrobacter species: significance of primary intraabdominal infection. Clin Infect Dis 23:543–549

    PubMed  CAS  Google Scholar 

  18. Kim BN, Woo JH, Ryu J, Kim YS (2003) Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia. Infection 31:202–207

    PubMed  CAS  Google Scholar 

  19. Fields BN, Uwaydah MM, Kunz LJ, Swartz MN (1967) The so-called “Paracolon” bacteria. A bacteriologic and clinical reappraisal. Am J Med 42:89–106. doi:10.1016/0002-9343(67)90008-3

    Article  PubMed  CAS  Google Scholar 

  20. Chen YS, Wong WW, Fung CP, Yu KW, Liu CY (2002) Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia. J Microbiol Immunol Infect 35:109–114

    PubMed  CAS  Google Scholar 

  21. Drelichman V, Band JD (1985) Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome. Arch Intern Med 145:1808–1810. doi:10.1001/archinte.145.10.1808

    Article  PubMed  CAS  Google Scholar 

  22. Samonis G, Ho DH, Gooch GF, Rolston KV, Bodey GP (1987) In vitro susceptibility of Citrobacter species to various antimicrobial agents. Antimicrob Agents Chemother 31:829–830

    PubMed  CAS  Google Scholar 

  23. Wang JT, Chang SC, Chen YC, Luh KT (2000) Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods. J Microbiol Immunol Infect 33:258–262

    PubMed  CAS  Google Scholar 

  24. Falagas ME, Kasiakou SK (2005) Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 40:1333–1341. doi:10.1086/429323

    Article  PubMed  CAS  Google Scholar 

  25. Nordmann P (1998) Trends in beta-lactam resistance among Enterobacteriaceae. Clin Infect Dis 27(Suppl 1):S100–S106

    Article  PubMed  CAS  Google Scholar 

  26. Park YJ, Park SY, Oh EJ, Park JJ, Lee KY, Woo GJ et al (2005) Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Diagn Microbiol Infect Dis 51:265–269. doi:10.1016/j.diagmicrobio.2004.11.009

    Article  PubMed  CAS  Google Scholar 

  27. Kim BN, Lee SO, Choi SH, Kim NJ, Woo JH, Ryu J et al (2003) Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species. Int J Antimicrob Agents 22:106–111. doi:10.1016/S0924-8579(03)00094-3

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece

    G. Samonis & D. P. Kofteridis

  2. Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 15 123, Marousi, Athens, Greece

    D. E. Karageorgopoulos, D. P. Kofteridis, D. K. Matthaiou & M. E. Falagas

  3. Department of Microbiology, University Hospital of Heraklion, Heraklion, Greece

    V. Sidiropoulou & S. Maraki

  4. Department of Medicine, Henry Dunant Hospital, Athens, Greece

    M. E. Falagas

  5. Department of Medicine, Tufts University School of Medicine, Boston, MA, USA

    M. E. Falagas

Authors
  1. G. Samonis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. E. Karageorgopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. P. Kofteridis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. K. Matthaiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Sidiropoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Maraki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. E. Falagas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. E. Falagas.

Additional information

Funding

None.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Samonis, G., Karageorgopoulos, D.E., Kofteridis, D.P. et al. Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis 28, 61–68 (2009). https://doi.org/10.1007/s10096-008-0598-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-008-0598-z

Keywords

Search

Navigation